Ligand validation:6RD3

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6RD3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6RD3_C8E_E_404	46%	74%	0.108	0.936	0.43	0.55	-	-	2	48%	0.4762
6RD3_C8E_A_503	44%	85%	0.117	0.904	0.42	0.33	-	-	0	67%	0.6667
6RD3_C8E_A_501	40%	83%	0.103	0.916	0.26	0.51	-	-	0	43%	0.4286
6RD3_C8E_B_805	36%	84%	0.105	0.908	0.26	0.49	-	-	0	38%	0.381
6RD3_C8E_E_401	36%	80%	0.107	0.899	0.25	0.59	-	-	0	43%	0.4286
6RD3_C8E_D_403	35%	86%	0.118	0.882	0.32	0.4	-	-	0	57%	0.5714
6RD3_C8E_B_804	33%	84%	0.15	0.932	0.28	0.47	-	-	0	43%	0.4286
6RD3_C8E_B_802	31%	88%	0.117	0.906	0.32	0.34	-	-	0	33%	0.3333
6RD3_C8E_B_807	29%	78%	0.148	0.88	0.43	0.46	-	-	0	57%	0.5714
6RD3_C8E_A_504	27%	82%	0.127	0.859	0.41	0.38	-	-	0	52%	0.5238
6RD3_C8E_F_401	25%	84%	0.168	0.915	0.28	0.47	-	-	0	38%	0.381
6RD3_C8E_A_502	23%	82%	0.159	0.884	0.26	0.53	-	-	0	43%	0.4286
6RD3_C8E_F_403	23%	82%	0.142	0.805	0.49	0.31	-	-	0	76%	0.7619
6RD3_C8E_E_402	21%	84%	0.149	0.877	0.28	0.47	-	-	0	33%	0.3333
6RD3_C8E_D_402	20%	92%	0.138	0.855	0.36	0.19	-	-	0	33%	0.3333
6RD3_C8E_C_402	18%	83%	0.151	0.852	0.39	0.39	-	-	0	33%	0.3333
6RD3_C8E_B_806	17%	77%	0.146	0.813	0.3	0.61	-	-	0	48%	0.4762
6RD3_C8E_D_405	15%	78%	0.185	0.823	0.55	0.34	-	-	2	57%	0.5714
6RD3_C8E_A_505	14%	88%	0.168	0.81	0.41	0.25	-	-	0	48%	0.4762
6RD3_C8E_B_808	14%	87%	0.148	0.788	0.41	0.28	-	-	0	48%	0.4762
6RD3_C8E_E_405	13%	87%	0.161	0.833	0.29	0.41	-	-	0	29%	0.2857
6RD3_C8E_D_404	13%	81%	0.199	0.841	0.27	0.55	-	-	1	43%	0.4286
6RD3_C8E_B_803	13%	82%	0.151	0.79	0.26	0.53	-	-	0	43%	0.4286
6RD3_C8E_B_801	12%	88%	0.175	0.811	0.34	0.33	-	-	1	38%	0.381
6RD3_C8E_E_403	12%	77%	0.165	0.766	0.32	0.58	-	-	0	57%	0.5714
6RD3_C8E_A_507	11%	87%	0.248	0.843	0.49	0.2	-	-	0	57%	0.5714
6RD3_C8E_F_402	8%	91%	0.229	0.816	0.4	0.16	-	-	0	38%	0.381
6RD3_C8E_C_401	7%	84%	0.18	0.725	0.48	0.29	-	-	0	43%	0.4286
6RD3_C8E_A_506	6%	76%	0.227	0.735	0.35	0.59	-	-	1	52%	0.5238
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	86%	0.8571

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6RD3

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 6RD3 designated by the RCSB